FCA authorised · FRN 7249520117 325 0027Quote & buy →
Apex Insurance Brokers
Speak to a brokerGet a quote →
APEX INSURANCE
Lloyd’s and market structure

Lloyd’s Lab

Category: Lloyd’s and market structure · Reviewed by the Apex broking team · Last reviewed 2026-08-22 · ~3 min read

In short: Lloyd’s Lab is the innovation accelerator run by Lloyd’s of London. It takes small cohorts of technology businesses through a ten-week programme inside the Lloyd’s building, with mentors drawn from the market, so that ideas can be tested against real underwriting, broking and claims problems. It is an accelerator, not an insurer and not a regulator.

Category: Lloyd’s and market structure
Also known as: the Lab, Lloyd’s Lab accelerator, Lloyd’s innovation accelerator
Related concepts: Lloyd’s of London, Lloyd’s syndicate, Lloyd’s managing agent

Definition

Lloyd’s Lab is Lloyd’s own accelerator programme for technology businesses working on insurance problems. Teams are selected competitively, spend a fixed period working alongside the market, and aim to leave with a validated product and, ideally, a syndicate or broker willing to run a pilot. It sits within Lloyd’s corporation activity rather than within any individual syndicate, and participation does not confer any regulatory status or any authority to underwrite.

Origins

Lloyd’s Lab opened on 3 September 2018, occupying a co-working space inside the Lloyd’s building in the City of London, and the first cohort began on 8 October 2018 with ten teams. The programme was created to give start-ups and scale-ups structured access to a market that is otherwise hard to enter, and to give the market a controlled way of trialling technology without committing to it.

How a cohort works

Each cohort runs for ten weeks. Selected teams get desk space in the building, a group of mentors drawn from across the market — underwriters, brokers, claims and operations people from managing agents and broking houses — and structured introductions to potential first customers. The cycle is competitive: applications are invited against published themes, a pitch stage selects the cohort, and the programme ends with a demo day at which the teams present what they have built. Lloyd’s runs cohorts on a recurring basis, with Cohort 16 announced during 2026.

What comes out of it

The recurring themes reflect what the market finds difficult: data and analytics for risk selection, automation of the placing and claims chain, tools for delegated authority oversight, climate and catastrophe modelling, and parametric structures that pay on a measured trigger rather than an adjusted loss. Alumni typically leave with a proof of concept and one or more market partners; some become suppliers to managing agents, some become coverholders, and some become the technology behind a product the market later sells. Related market concepts are covered in InsurTech, parametric insurance and delegated authority.

What it is not

Three clarifications matter for buyers. Lloyd’s Lab does not carry risk: it is not an insurer and no policy is issued by it. It is not a regulatory approval: taking part says nothing about a firm’s FCA or PRA permissions. And it is not a warranty of longevity — an accelerator is by design a place where ideas are tested, and not every idea tested survives. If a product is presented to you as “from the Lloyd’s Lab”, the questions to ask are who the risk carrier is, what the security is, and who holds the binding authority.

Why a commercial buyer should care

Two reasons. First, an increasing share of specialist capacity reaches buyers through structures — parametric triggers, embedded cover, data-driven underwriting — that were prototyped in programmes of this kind, and understanding where they came from helps in reading the wording. Second, newer products often behave differently at claim: a parametric policy pays on a trigger regardless of actual loss, which is attractive for speed and unhelpful if the trigger and the loss diverge. Novelty is not a reason to avoid a product, but it is a reason to read it against the rest of the programme rather than in isolation.

Frequently asked questions

Is Lloyd’s Lab an insurer?

No. It is an accelerator programme run by Lloyd’s of London. It does not underwrite risk and does not issue policies. Any cover associated with a participating business is written by an authorised carrier.

How long is a Lloyd’s Lab cohort?

Ten weeks. Teams work from a co-working space inside the Lloyd’s building with mentors drawn from across the market, and the programme concludes with a demo day.

When did Lloyd’s Lab start?

It opened on 3 September 2018 and the first cohort began on 8 October 2018. Cohorts have run on a recurring basis since, with Cohort 16 announced during 2026.

Related entries


This entry is part of the Apex Insurance Wiki. Position stated as at August 2026. Last reviewed 2026-08-22. Next review: 2027-02-22. It is general insurance information, not legal advice, and not regulated advice on a specific policy.

New product, old questions
Whoever built it, the questions are the same: who carries the risk, and what does the wording say? Bristol-based, FCA-regulated, wordings first.
Call 0117 325 0027  info@apexinsurancebrokers.co.uk

Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority (FRN 724952). This page is general information, not advice on a specific policy.

Want a broker to look at your commercial cover?
If you have your renewal pack, Statement of Fact or schedule, send it over and we’ll come back with options — no forms to fill in. Arranging cover for the first time? That works too. Or call 0117 325 0027.
Start a commercial quote →
Larger or multi-site risk? We’ll come and see you.
Get a quote →